Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1998-01-06
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514464, 514367, 514469, 514375, 514422, 514321, 514320, 514253, 5142338, 5142335, 548178, 548217, 548517, 548518, 549467, 549434, 546198, 546196, 544135, 544137, 544 8, 544148, 544153, C07D41312, C07D40712, C07D41712, A61K 31335, A61K 3154, A61K 31535, A61K 31495, A61K 3134
Patent
active
057055009
ABSTRACT:
Selected sulfonylalkanoylamino hydroxyethylamine sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.
REFERENCES:
patent: H725 (1990-01-01), Gordon
patent: 4450164 (1984-05-01), Gordon et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4595407 (1986-06-01), Carter
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4634465 (1987-01-01), Ehrenfreund et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4880938 (1989-11-01), Freidinger
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 4983530 (1991-01-01), Hemmi et al.
International Search Report of PCT/US96/02682 dateD 21 Aug. 1996.
Roberts et al, Science, 248, 358 (1990).
Erickson et al,. Science, 249, 527 (1990).
Pearl et al, Nature 328 (1987).
Martin, Drugs of the Future, (1991), 16(3), 210-212.
Meek et al, Nature, 343:90-92, (1990).
McQuade et al, Science, 274, 454 (1990).
Rich et al, Pept. Struct. Funct. Am. Pept. Sym. 8th ed. pp. 511-520 (1983).
Rosenberg et al, J. Med. Chem., 30, 1224-1228 (1987).
Fittkau, J. Prakt. Chem., 315, 1037 (1973).
Hirsh et al, N. Eng. J. Med., 328, 1686 (1993).
E.E. Gilbert, "Recent Developments in Preparative Sulfonation and Sulfation", Synthesis, 3 (1969).
Mitsuya et al., Proc. Natl. Acad. Sci. USA, 83, 1911-15 (1986).
Silcox et al, J. Heterocycl Chem., 4, 166-67 (1967).
Cabiddu et al, Synthesis, 797-798 (1976).
Ncube et al, Tet. Lett, 26, 2345-2348 (1978).
Ncube et al, Tet. Lett., 3, 255-256 (1977).
Cole et al, Aust. J. Chem., 33, 675-80 (1980).
DeCrescenzo Gary A.
Devadas Balekudru
Freskos John N.
Getman Daniel P.
McDonald Joseph J.
Cross Laura R.
G.D. Searle & Co.
Richter Johann
Ungemach Frank s.
LandOfFree
Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329331